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Best’s vitelliform macular dystrophy is an autosomal dominant disorder of unknown causes. To identify the
underlying gene defect the disease locus has been mapped to an ∼1.4-Mb region on chromosome 11q12–q13.1. As
a prerequisite for its positional cloning we have assembled a high coverage PAC contig of the candidate region.
Here, we report the construction of a primary transcript map that places a total of 19 genes within the Best’s
disease region. This includes 14 transcripts of as yet unknown function obtained by EST mapping and/or cDNA
selection and five genes mapped previously to the interval (CD5, PGA, DDB1, FEN1, and FTH1). Northern blot
analyses were performed to determine the expression profiles in various human tissues. At least three genes
appear to be good candidates for Best’s disease based on their abundant expression in retina or retinal pigment
epithelium. Additional information on the functional properties of these genes, as well as mutation analyses in
Best’s disease patients, have to await their further characterization.
[The GenBank/EMBL accession numbers and details of the isolation, localization, and characterization of ESTs
and selected cDNAs are available as online supplements in Online Tables 1–3 at http://www.genome.org.]
The macular dystrophies are a heterogenous group
of distinct disorders characterized by morphological
changes most profoundly in the central fundus and
loss of central vision assumed to result preferentially
from degeneration of cone photoreceptors. In re-
cent years, almost 20 hereditary maculopathies
have been localized to specific chromosomal re-
gions (for review, see Sullivan and Daiger 1996), lay-
ing the groundwork for the identification of the un-
derlying disease genes by applying the various strat-
egies of positional cloning (Collins 1995). To date,
five genes associated with macular dystrophy have
been identified: (1) The peripherin/retinal degenera-
tion slow (RDS) gene when mutated can result in
typical macular as well as retinitis pigmentosa (RP)
phenotypes (Dryja et al. 1990; Kajiwara et al. 1993;
Nichols et al. 1993; Wells et al. 1993); (2) the tissue
inhibitor of metalloproteinase-3 (TIMP3), causing
autosomal dominant Sorsby’s fundus dystrophy
(Weber et al. 1994); (3) the photoreceptor-specific
ABC transporter (ABCR) implicated in autosomal re-
cessive Stargardt’s macular dystrophy (Allikmets et
al. 1997); (4) ataxin-7 (SCA7), which is associated
with progressive cerebellar ataxia as well as pigmen-
tary macular dystrophy (David et al. 1997); and (5)
the RS1 gene underlying X-linked juvenile retinos-
chisis (Sauer et al. 1997).
Our current efforts are directed toward the iso-
lation of the gene responsible for Best’s vitelliform
macular dystrophy (Best’s disease) (Best 1905). This
disorder is characterized by an autosomal dominant
mode of inheritance, with symptoms generally
manifesting in the first or second decade of life. A
subretinal eggyolk-like lesion in the macular area
represents the most prominent feature of the dis-
ease. Histopathologically, an unusual accumulation
of yellowish material is found at the level of the
retinal pigment epithelium (RPE), probably between
the RPE and Bruch’s membrane. It is composed of
viscous, lipofuscin-like granula likely constituting
incompletely digested remnants of the outer seg-
ments of the photoreceptor cells (Weingeist et al.
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1982; O’Gorman et al. 1988). Electrodiagnostic test-
ing demonstrates a typically reduced electro-
oculogram (EOG) in the affected individuals, even
in those patients with otherwise normal fundus ap-
pearance. Electrophysiology, together with the his-
topathological findings, favors a generalized dys-
function of the RPE complex as the basic defect in
Best’s disease.
As a first step toward the cloning of the disease
gene, the Best’s disease locus was mapped to chro-
mosome 11 by genetic linkage analysis (Forsman et
al. 1992; Stone et al. 1992). Subsequently, a detailed
characterization of recombinant chromosomes in
large Best’s disease pedigrees has refined the disease
locus to a 1- to 2-cM interval in 11q12–13.1 flanked
by markers at D11S1765 proximally and uteroglo-
bin (UGB) distally (Sto¨hr and Weber 1995; Wadelius
et al. 1996). As a prerequisite to the construction of
a comprehensive gene map of the disease region we
have recently assembled a sequence-ready PAC con-
tig providing full coverage of the minimal 1.4-Mb
Best’s disease locus (Cooper et al. 1997).
The identification of coding sequences within
large genomic regions is still a challenging and for-
midable task, although a variety of advanced tech-
nologies is available to date (for review, see Parimoo
et al. 1995). Currently, several approaches are widely
used and include the exon trapping/amplification
technique (e.g., Buckler et al. 1991), direct cDNA
selection (e.g., Morgan et al. 1992; Rommens et al.
1993), identification of CpG islands (Lindsay and
Bird 1987), and computational-based methods for
the prediction of protein-coding potentials in ge-
nomic sequences (Uberbacher and Mural 1991). Be-
cause no single approach appears to be efficient
enough to identify all and, in particular, the rare
transcripts within a specific genomic region, it is de-
sirable to apply a combination of these techniques.
Five genes, CD5, PGA, DDB1, FEN1, and FTH1,
as well as seven EST clones have been mapped pre-
viously to the Best’s disease region (Cooper et al.
1997). Here we have expanded the mapping of
known ESTs and have performed a PCR-based cDNA
selection of large parts of the critical region using
cDNA pools derived from eye tissues that most
likely express the gene underlying Best’s disease,
namely the retina and the RPE. Based on Northern
blot analyses the identified cDNA fragments have
been assembled into 14 distinct transcripts, thus in-
creasing the total number of known genes in the
Best’s disease region to 19. This primary transcript
map provides the starting point for further charac-
terizations of potential candidates for the Best’s dis-
ease gene.
RESULTS
Refined Mapping of Known ESTs
To further refine the localization of 15 ESTs assigned
previously to proximal 11q by radiation hybrid RH
mapping (Schuler et al. 1996; Shows et al. 1996) a
minimal set of overlapping PAC clones encompass-
ing the minimal Best’s disease locus were used for
EST content mapping by PCR and/or Southern blot
analyses of EcoRI-digested cloned DNA. In addition,
several YAC clones were analyzed, extending the
PAC contig ∼1 Mb centromeric and 300 kb telo-
meric (Qin et al. 1996; Cooper et al. 1997) (Fig. 1A).
Of the 15 ESTs, two mapped within the Best’s dis-
ease locus, whereas four EST clones were localized to
CEPH Mega YAC 942 g 8 and one EST to YACs
yRP6a5 and yRP16b1, thus positioning these tran-
scripts outside the disease region proximal to
D11S1765 [Fig. 1A and online supplements (Online
Table 1, http://www.genome.org)]. The location of
the remaining eight ESTs could not be determined
within the genomic clones utilized in this study.
Isolation and Physical Mapping of Clones Obtained
by Direct cDNA Selection
To identify novel cDNAs from the Best’s disease lo-
cus we performed direct cDNA selection using seven
PAC clone DNAs covering ∼800 kb of the core Best’s
disease region (Fig. 1C). The primary cDNAs were
generated from total RNA of retinal tissue and cell
line ARPE-19 and were subsequently pooled for two
rounds of hybridization-based selection with PAC
insert DNAs. Three separate experiments were per-
formed using PAC clone dJ71C4 (denoted C96),
PAC clones dJ455M17, dJ527E4, and dJ465G21 (de-
noted C97A); and PAC clones dJ139E20, dJ379A21,
and dJ221L18 (denoted C97B) [Fig. 1C and online
supplements (Online Tables 2 and 3, http://
www.genome.org)]. Initial overlap between dJ71C4
and dJ455M17 during PAC contig assembly could
not be verified, leaving a small gap of ∼30 kb of
genomic DNA between dJ71C4 and dJ455M17 not
included in the cDNA selection (Fig. 1C). A total of
182 clones were retrieved (C96, 41 clones; C97A, 95
clones; C97B, 46 clones) and arrayed into 96-well
microtiter plates. The insert sizes were determined
by PCR with oligonucleotide primers M13f/M13r
flanking the EcoRI cloning site of the pBluescript vec-
tor and were found to range from 200 bp up to 2 kb.
Subsequently, the genomic origins of the se-
lected cDNA fragments were verified by Southern
hybridization to EcoRI-digested PAC clone mem-
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branes. In total, 29 (16%) cDNA fragments failed to
hybridize specifically to the originating PAC clones.
Based on sequential hybridizations of single cDNA
clones to the membrane-spotted arrayed cDNAs, the
remaining 153 retrieved cDNAs were assembled into
46 contigs. Twelve contigs were found to contain
individual clones composed of >50% of interspersed
repeat elements and were excluded from further
analysis. The remaining 34 contigs were regionally
assigned to dJ71C4 (9), dJ455M17, dJ527E4, and
dJ465G21 (1), dJ527E4 and dJ465G21 (13),
dJ465G21 (2), dJ139E20 and dJ379A21 (1),
dJ379A21 and dJ221L18 (2), and dJ221L18 (6) (data
not shown). DNA sequences of selected clones from
each cDNA contig were determined and subjected
to BLAST searches against nucleotide and protein
sequence databases accessible through the National
Center for Biotechnology Information (NCBI) via
the internet (http://www.ncbi.nlm.nih.gov/BLAST/).
Identification of Sequences of Known Human Genes
Sequence alignments to the nonredundant Gen-
Bank/EMBL databases demonstrated significant
similarities of five individual cDNA contigs to vari-
ous regions of three human genes, namely to the
damage-specific DNA-binding protein-1 (DDB1),
the flap endonuclease-1 (FEN1) and the ferritin
heavy-chain-1 (FTH1) (Online Table 2). The three
genes have been localized independently to the
chromosome 11q12–q13 region by FISH and RH
mapping (Hentze et al. 1986; Dualan et al. 1995;
Hiraoka et al. 1995) in excellent agreement with our
PAC mapping data (Fig. 1B, D).
Figure 1 Schematic representation of the physical and transcript map of the Best’s disease locus. (A) Two
nonoverlapping YAC contigs extending the Best’s disease region proximally and distally. The order and location of
genes and anonymous DNA markers were determined by STS content mapping. (B) The minimal Best’s disease
interval between DNA markers at D11S1765 and UGB. The physical size of the region and the position of known
genes and STSs is shown. (C) A selected set of overlapping PAC clones (Cooper et al. 1997) covering ∼1 Mb of
genomic DNA of the candidate region was used to localize 17 distinct transcription units (TUs). Bold bars indicate
PAC clone DNAs used for cDNA selection. (D) Regional assignment of 17 distinct TUs. The transcript sizes obtained
by Northern blot analysis are in parentheses.
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Clone contigs C96-1, C96-2, and C96-3 revealed
sequence identity to distinct regions of the DDB1
cDNA (Dualan et al. 1995) (Online Table 2). Map-
ping of these contigs to PAC clone dJ71C4 or
dJ398K24/dJ71C4 allowed us to determine the ori-
entation of transcription of the DDB1 gene from
telomere to centromere (Fig. 1C). Clone contig
C97A-6 demonstrated identity to the 38 UTR of
FEN1 and was mapped to dJ527E4 and dJ465G21. In
addition, the left end fragment from ICI–YAC 1EE1,
1EE1L (Fig. 1A), was sequenced and found to con-
tain the 58 end of FEN1, thus establishing the ori-
entation of transcription of FEN1 from centromere
to telomere. Finally, sequence alignment of the 439-
bp fragment C97B-1 revealed 99% similarity to the
published cDNA sequence of FTH1 (Boyd et al.
1984). A second ferritin heavy-chain gene, namely
FTHL16, is known to map to chromosome 11q13
(Papadopoulos et al. 1992). However, sequence
alignment with C97B-1 revealed 22 mismatches to
the FTHL16 sequence, demonstrating that clone
C97B-1, originating from the FTH1 locus, is the only
known functional member of the FTH multigene
family (Hentze et al. 1986).
Identification of Sequences of Unknown Function
Fifteen of the remaining 29 cDNA contigs revealed
significant sequence matches in the dbEST database
(Online Table 3). Six contigs identified EST clusters
that were independently assigned to the proximal
long arm of chromosome 11 (UniGene server at
http://www.ncbi.nlm.gov/UniGene/index.html)
(Online Table 1). In addition, cDNA contig C96-7
and D11S2319E are part of a single EST contig that
has been positioned within the Best’s disease region
(Online Tables 1 and 3). Likewise, cDNA contig
C96-8 partially overlaps EST173048, previously lo-
calized to the D11S1765–UGB interval by EST con-
tent mapping (Online Tables 1 and 3).
Expression Analysis
The expression profiles of ESTs and a representative
clone of each of the 34 cDNA contigs mapping to
the Best’s disease locus were analyzed by Northern
blot analyses with emphasis on retina and retinal
pigment epithelium. In addition, database searches
were carried out to evaluate the representation of
the cDNAs in tissue-specific cDNA libaries (Fig. 2;
Table 1). Based on the localization to an identical
genomic interval, a common transcript size, and an
identical expression profile the cDNA fragments
subsequently were assigned to distinct transcription
units (TUs). Accordingly, we identified 17 TUs that
were consecutively numbered from centromere to
telomere (Fig. 1D; Table 1).
TU 4–TU7, TU11 (FEN1), TU14 (FTH1), TU16,
and TU17 appear to be expressed ubiquitously with
a single transcript size present in all tissues tested
(TU7 and TU14 are shown in Fig. 2). Using cDNA
fragment IXD11 corresponding to FTH1 (Online
Table 2) we detected a single transcript of 1.1 kb in
all tissues tested including cerebellum (Fig. 2). An
additional transcript of 1.4 kb recently identified in
brain tissue (Dhar et al. 1993) could not be con-
firmed even after a prolonged exposure time.
TU1 (DDB1), TU3, and TU12, although widely
expressed, show a higher abundance in some tis-
sues. Interestingly, TU1 and TU3 are highly ex-
pressed in retina (Fig. 2). Similarly, the 4.0-kb mRNA
of TU12 has a high abundance in cell line ARPE-19
(Fig. 2).
TU9 was originally isolated from a retina cDNA
library (EST387646) (Online Table 1 and Table 1).
Northern Blot analysis identified a 7.5-kb transcript
in skeletal muscle, kidney, and more weakly in pla-
centa (Fig. 2); however, no detectable signals were
observed in retinal and ARPE-19 mRNA (data not
Figure 2 Northern blot analyses of cDNA fragments
corresponding to the (TUs) as indicated (see Fig. 1).
Examples are given to demonstrate the various expres-
sion profiles in lung (lane 1), cerebellum (lane 2), retina
(lane 3), retinal pigment epithelium cell line ARPE-19
(lane 4), and heart (lane 5), brain (lane 6), placenta
(lane 7), liver (lane 8), skeletal muscle (lane 9), kidney
(lane 10), and pancreas (lane 11). The transcript sizes
are indicated at left in kilobases.
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shown). TU2, TU10, and TU15 appear to be specifi-
cally expressed in lung and ARPE-19, with TU10
highly abundant in the cell line RNA (Fig. 2).
TU8 displayed at least three species, a 7.0-kb
mRNA in brain, liver, pancreas, and placenta, with
single additional transcripts of 7.5 and 5.5 kb in
brain and placenta, respectively (Fig. 2). TU13 is rep-
resented as 4-kb and 3.1-kb transcripts in cerebel-
lum and retina. Only the larger transcript appeared
in lung and the smaller species in the cell line ARPE-
Table 1. Expression Analysis of TUs
TU
Size
(kb) Tissue specificity
Representation in tissue-specific
cDNA librariesa
TU1 (DDB1) 4.2 all tissues tested, with higher expression
in retinab
placenta, fetal heart, fetal liver/spleen,
fibroblast, fetal lung, blood peripheral
lymphocytes, ovary, breast, brain
TU2 2.8 lung, ARPE-19b melanocyte, fetal heart, infant brain,
pregnant uterus, HeLa, placenta, uterus
tumor, total fetus, endothelial cell,
ovary tumor
TU3 1.3 all tissues tested, with higher expression
in retinab
e.g., melanocyte, placenta, breast, fetal
heart, pregnant uterus, fetal
liver/spleen, retina, fetal heart, fetal
cochlea, fetal lung
TU4 1.1 all tissues testedb fetal liver/spleen, fetal heart, infant and
adult brain, melanocyte, thyroid, fetal
lung, embryo
TU5 4.0 all tissues tested, with higher expression
in lungb,c
infant brain
TU6 1.9 all tissues testedb fetal liver/spleen
TU7 1.4 all tissues testedb placenta, fetal liver/spleen, brain,
melanocyte, multiple sclerosis lesions,
fetal heart
TU8 7.5 brain infant brain
7.0 brain, liver, pancreas, placeta
5.5 placentac
TU9 7.5 placenta, skeletal muscle, kidneyb,c retina
TU10 5.7 lung, ARPE-19, with higher expression in
ARPE-19b
infant and adult brain, multiple sclerosis
lesions, colon carcinoma, ovary tumor,
cerebellum, hippocampus
TU11 (FEN1) 2.3 all tissues testedb infant brain, fetal liver/spleen, placenta,
heart
TU12 4.0 all tissues tested, with higher expression
in ARPE-19b
brain, fetal heart, fetal liver/spleen,
neuroepithelium, melanocyte
TU13 4.0 lung, cerebellum, retina fetal/liver spleen, infant brain
3.1 cerebellum, retina, ARPE-19b
TU14 (FTH1) 1.1 all tissues testedb lung, HeLa, fetal heart, placenta, fetal
liver/spleen, fetal lung, endothelial, fetal
spleen, pancreatic islets, brain
TU15 3.5 lung, ARPE-19b fetal liver/spleen, pancreas tumor, retina
TU16 1.1 all tissues testedb fetal liver/spleen, colon, B cell, skeletal
muscle, lung
TU17 1.6 all tissues testedb —
aData have been obtained from BLAST searches against dbEST and/or from the UniGene server at http:/www.ncbi.nlm.gov/UniGene/
index.html.
bLung, cerebellum, retina, ARPE-19 (total RNA blot).
cHeart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas [poly(A)+ RNA blot, Clontech].
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19 (Fig. 2), suggesting that this gene is subjected to
alternative splicing that may be tissue specific.
DISCUSSION
Despite major achievements of the International
Human Genome Project, to date, positional cloning
of a disease gene is still a formidable task. In the case
of Best’s disease extensive analyses of recombinant
disease chromosomes have narrowed the locus har-
boring the disease gene to an interval encompassing
∼1.4 Mb of DNA (Sto¨hr and Weber 1995; Wadelius
et al. 1996). Thus far, five genes have been localized
within this interval (Cooper et al. 1997), encoding
pepsinogen A (PGA) (Evers et al. 1989), a membrane
glycoprotein of lymphocytes (CD5) (Jones et al.
1986), the p127 subunit of a damage-specific DNA-
binding protein DDB1 (Dualan et al. 1995), the fer-
ritin heavy-chain subunit of the iron-storage
protein ferritin (FTH1) (Hentze et al. 1986), and
the structure-specific flap endonuclease (FEN1)
(Hiraoka et al. 1995). Although a possible involve-
ment of one of these genes in the pathogenesis of
Best’s disease remains to be shown, the functional
properties of the corresponding proteins appear not
to provide supporting evidence for their candidacy.
To identify additional genes within the Best’s
disease region and possibly those with functional
relevance to the disease pathology, we have applied
a combination of two approaches.
First, we have made use of the availability of an
increasing number of ESTs that are localized to
chromosome 11q12–q13 by RH mapping (Schuler et
al. 1996). Of 22 EST clones assigned previously to
the interval between markers at D11S1357 and
D11S913 by RH mapping, a total of nine cDNAs
(41%) were found to reside within the crucial region
between D11S1765 and UGB (Cooper et al. 1997;
Online Table 1). Northern blot analyses of these
cDNA fragments revealed a minimum of six distinct
transcripts. Another five EST clones were positioned
outside the Best’s disease locus within an ∼1 Mb
region proximal to D11S1765. From these results we
conclude that refined EST mapping is a useful and
reasonably efficient method to add novel transcripts
to a genomic region of interest.
Second, we performed direct cDNA selection
(Rommens et al. 1993) using cDNA pools from reti-
nal tissue and the RPE cell line ARPE-19. Based on
electrophysiological and histopathological data one
can assume that the defective gene is expressed in
one of these eye tissues. Overall, this approach has
led to the identification of 13 transcripts with dis-
tinct signals on Northern blot analyses. It is of note
that all three genes (DDB1, FEN1, and FTH1) and
two EST clones (EST173048, D11S2319E) known to
reside within the analyzed genomic region were rep-
resented in the retrieved cDNA clones, thus demon-
strating the high sensitivity and efficiency of the
method used.
We have mapped an additional 17 unrelated
cDNA fragments to the disease interval but could
not detect mRNA signals in Northern blot hybrid-
izations of total RNA preparations. Although for
practical purposes we have not included these
cDNAs in our primary transcription map, low or
cell-specific expression within a given tissue may
account for the lack of Northern blot signals. There-
fore, we intend to further characterize these possible
low copy transcripts with respect to their presence
in RT–PCR experiments and in retinal cDNA librar-
ies. In contrast to the analysis of abundant tran-
scripts, the identification of rare RNA species re-
quires a disproportionally greater effort.
Sequence analyses of the retrieved cDNA clones
have revealed a remarkably high percentage (40%)
of fragments containing repetitive elements, with
the great majority of repeats representing various
members of the Alu repeat family (Schmid and Je-
linek 1982). One can assume that these findings re-
flect the presence of unprocessed RNA fragments in
the total RNA preparations used for first-strand
cDNA synthesis. Accordingly, an illegitimate prim-
ing event of the RXGT12 oligonucleotide to
stretches of adenine nucleotides present in Alu or L1
elements would then generate exon/intron-
containing cDNA fragments. In support of this
mechanism are our findings in at least two retrieved
cDNA clone contigs [C96-1 (DDB1) and C97A-7]
that unambiguously show the presence of coding
sequences flanked by conserved splice acceptor and
donor sites. Similar observations have been reported
previously (Rommens et al. 1995) and have led to
the suggestion that the unprocessed cDNAs may be
favored in the selection process because of the en-
larged target size that allows a more efficient anneal-
ing of cDNA/DNA molecules.
Thus far, of the 14 novel transcripts identified
within the Best’s disease locus, no information re-
garding their possible function could be derived
from DNA sequence or protein pattern database
searches. This may be attributable primarily to a po-
tential selection bias toward retrieved cDNA frag-
ments originating from the 38 UTRs of the respective
genes, thus revealing little or no coding informa-
tion. In the absence of this crucial piece of informa-
tion the criteria for the assessment of candidate
genes for Best’s disease has to be based purely on
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their expression profiles in various tissues. Consid-
ering the etiology of Best’s disease, several tran-
scripts identified in this study are interesting candi-
dates for the disease gene (e.g., TU3, TU10, or
TU12). Their further characterization and muta-
tional analysis in Best’s disease patients is currently
in progress.
In summary, we have identified 14 novel tran-
scripts by EST mapping and cDNA selection and
have determined their expression patterns in vari-
ous human tissues, including retina and retinal pig-
ment epithelium. In addition, the precise location
of these transcripts within the genomic locus har-
boring the Best’s disease gene was determined. To-
gether with the five known genes mapped previ-
ously to this interval (CD5, PGA, DDB1, FEN1, and
FTH1), this increases the number of distinct genes
in the disease region to 19. As the physical size of
the interval can be estimated to be ∼1.4 Mb, the
primary transcription map contains, on average,
one gene every 73 kb of genomic DNA. The gene
density in this region may even be higher as addi-
tional genes with tissue-specific expression other
than retina and RPE will likely be added to the pri-
mary transcript map. Therefore, we conclude that
the Best’s disease region represents one of the more
gene-rich regions of the human genome (Fields et
al. 1994). Beyond the identification of the Best’s dis-
ease gene itself, the complete molecular character-
ization of this region will add to the efforts aimed at
the construction of comprehensive gene and ex-
pression maps of the human genome.
METHODS
Genomic Clones
As part of the framework physical map of chromosome 11,
YAC clones were isolated from the RPCI chromosome 11-
specific YAC library, the CEPH Mega YAC library, and the
London ICI–YAC library and assembled into 142 contigs (Qin
et al. 1996). For the refined mapping of known ESTs several
YAC clones were selected from two nonoverlapping YAC con-
tigs extending the minimal Best’s disease interval in 11q12–
q13.1 proximally and distally (Fig. 1A). Yeast cultures were
grown in AHC complete medium [1.7 grams /liter of yeast
nitrogen base without amino acids and (NH4)2SO4, 5.0 mg/
liter of (NH4)2SO4, 10 mg/liter of casein, 20 mg/liter of ad-
enine hemisulfate, adjusted to pH 5.8], and total chromosomal
yeast DNA was isolated as described (Scherer and Tsui 1991).
For EST content mapping a minimal set of overlapping
PAC clones were selected covering the entire Best’s disease
region (Cooper et al. 1997). For cDNA selection seven PAC
clones were used from the central region of the disease locus
(Fig. 1C). The clones were grown in overnight cultures of LB
broth containing 50 µg/ml of kanamycin followed by the iso-
lation of PAC DNA using the standard alkaline lysis tech-
nique.
Fine Mapping of Known EST Clones
PCR-based EST mapping was performed using PAC or YAC
DNAs as template and oligonucleotide primers designed ac-
cording to the published sequences in the databases (Gen-
Bank accession nos. are given in Online Table 1). Reaction
mixtures contained ∼50 ng of template DNA, 15 pmoles of
each primer, 1.25 mM dNTPs, and 12 PCR buffer supple-
mented with 1–2 mM MgCl2 and 0.5 units of Taq DNA poly-
merase. The reaction mixture was denatured once at 94°C for
5 min and was subsequently subjected to 33 cycles of 30 sec at
94°C, 30 sec at an annealing temperature optimized for each
primer pair (55°C–60°C), and 30 sec at 72°C, followed by a
final extension of 5 min.
Alternatively, the mapping experiments included South-
ern blot analyses of EST clones obtained from the IMAGE
Consortium clone distributors to EcoRI-digested PAC DNA.
Restriction enzyme digestions were carried out as recom-
mended by the manufacturer (GIBCO BRL) followed by elec-
trophoresis and blotting to Hybond-N+ membranes (Amer-
sham) using standard procedures. DNAs from individual
cDNA clones were isolated, digested with specific restriction
enzymes to excise the respective insert, and separated electro-
phoretically. Insert fragments were purified in low melting
point agarose (Bio-Rad) and radiolabeled by random oligo-
nucleotide priming. Hybridizations were carried out in 0.5 M
sodium phosphate buffer (pH 7.2), 7% SDS at 65°C (Church
and Gilbert 1984).
Direct cDNA Selection
Total RNA was prepared either from frozen tissues or from cell
line ARPE-19 derived from human RP epithelium (Dunn et al.
1996) using the RNA-Clean-LS system (Angewandte Gentech-
nologie Systeme). The cDNA selection was performed essen-
tially as described (Rommens et al. 1993), with only minor
modifications. Briefly, RNAs were reverse transcribed using
the Superscript preamplification system for first-strand cDNA
synthesis (GIBCO BRL) and the RXGT12 oligonucleotide
primer (58-CGGAATTCTCGAGATCTTTTTTTTTTTTT-38). Af-
ter poly(A) tailing with terminal transferase (U.S. Biochemi-
cal), a cDNA pool was generated by RXGT12-primed PCR at
94°C for 1 min; 2 cycles of 94°C for 30 sec; 37°C for 1 min,
72°C for 2 min, followed by 22 cycles of 94°C for 30 sec; 58°C
for 30 sec, and 72°C for 2 min. Prior to hybridization the
cDNA pools were preannealed to Cot-1 DNA (GIBCO BRL)
enriched with sonicated LINE1 sequences (clones pA10 and
pA12 containing 3.4 kb of the 38 end and 4.1 kb of the 58 end
of the LINE/L1 fragment, respectively, were kindly provided
by C. Collins, University of California, San Francisco). PAC
clone inserts (∼1 µg) were isolated by NotI digestion, purified
using QIAEXII agarose gel extraction beads (Qiagen), and im-
mobilized on Hybond-N+ membrane filters with an average
concentration of 60 ng/mm2. The insert filters were subjected
to two consecutive rounds of hybridization with a starting
mixture of 20 µg of retina and ARPE-19-derived cDNAs. Hy-
bridization time was 4 days at 58°C in Church hybridization
buffer (Church and Gilbert 1984). Filters were washed three
times in 22 SSC/0.1% SDS at room temperature, once each in
0.52 SSC/0.1% SDS, 0.22 SSC/0.1% SDS, and 0.22 SSC/
0.05% SDS (all at 58°C). A final wash was in 22 SSC. cDNAs
were eluted in distilled H2O by incubating for 10 min at 98°C
and reamplified by PCR using the RXGT12 oligonucleotide
primer. Four micrograms of the reamplified cDNAs were used
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for a second round of hybridization. After two rounds of se-
lection the cDNAs were amplified using the RXGT12 oligo-
nucleotide primer, digested with EcoRI and cloned into the
EcoRI site of pBluescript (Stratagene).
Analysis of Selected cDNA Clones
Individual cDNA clones were archived in 96-well microtiter
plates containing 100 µl of LB/ampicillin. To determine cDNA
clone redundancy and to verify the genomic origin of the
selected cDNA clones, insert fragments were individually PCR
amplified with oligonucleotide primer RXGT12 and consecu-
tively hybridized to nylon membranes containing the gridded
cDNAs and EcoRI-digested PAC clone DNAs. Prior to hybrid-
ization, fragments were preannealed with sonicated human
placental DNA (Sigma).
Sequencing of 300–400 bp of the 58 and 38 ends of se-
lected cDNA clones was carried out by the dideoxy chain ter-
mination method using the Sequenase version 2.0 DNA se-
quencing kit (U.S. Biochemical). Sequences were analyzed us-
ing the MacVector program version 4.1.4 (Kodak) and
publicly available nucleotide and protein databases at the
NCBI (Gish and States 1993). GenBank accession numbers of
retrieved cDNA sequences are given in Online Table 3.
Northern Blot Analysis
Total RNAs (12 µg) isolated from frozen lung, cerebellum,
retinal tissue, and cell line ARPE-19 were separated electro-
phoretically in 1.2% agarose gels containing 0.6 M formalde-
hyde and vacuum blotted onto Hybond-N+ membranes. Re-
peated hybridizations with radiolabeled cDNA inserts were
performed as described for the mapping of EST clones above.
Final washing conditions were 0.22 SSC/0.1% SDS at 55°C.
Multiple-tissue Northern blot membranes containing 2 µg of
poly(A)+ RNA were purchased and used repeatedly according
to the supplier’s recommendations (Clontech). Stripping of
bound cDNA inserts from the membranes was done by incu-
bating in boiled solution of 0.012 SSC/0.01% SDS.
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